Thomas LongClaims for methods of administering beta-alanine to increase muscles’ working capacity were valid treatment claims, not merely directed to natural laws. Claims for the supplement products and means of making them were directed to specific formulations, not natural phenomena. Case date: 15 March 2019 Case number: No. 2018-129 Court: United States Court of Appeals, Federal Circuit A full summary of this case has been published on Kluwer IP Law. More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Patent Law Injunctions by Rafal Sikorski€ 181
Read more detail on Recent Intellectual Property Law posts –
Related news:
- U.S. Court of Appeals for the Sixth Circuit, Dimond Rigging Company, LLC v. BDP International, Inc.; Logitrans International, LLC, Docket No. 18-3615, Boggs, Circuit Judge, recommended for full-text publication
- Attempted Case of Wildlife Smuggling Reminds the International Community of Its Prevalence
- A note from Dean Michael Scharf, Founder and Editorial Board Advisor of War Crimes Prosecution Watch, on Case Western Reserve University’s new International Criminal Law LLM Program
- Lex Machina’s Annual Patent Litigation Report: Decline in Case Filings
- U.S. Patent System Jumps to Tie for Second Place in International IP Index
- Patent case: SSH Communications v Sony Mobile Communications & ors, United Kingdom
- Patent case: Tretkurbeleinheit, Germany
- Indiana Copyright Litigation: Dexas International, Ltd. Seeks Judgment in Cutting Board Case
- False patent marking claim fails in cannabis case despite clear falsity/motive to crush competition: mostly it didn't work
- Indiana Supreme Court issues Opinion in Daniels vs. FanDuel, Inc. Right of Publicity Case
